Study: FDA Regulation of Abortion Drug Mifepristone from 2011 to 2023 Shaped by Evidence and Caution

ChaseJanuary 14, 2026

Review of hundreds of internal FDA documents obtained under FOIA finds FDA generally followed cautious and evidence-based recommendations from staff scientists.

Abortion Pills FDA Healthcare Reproductive rights United States

By Chase